ArticleBMC infectious diseases2025
Epidemiological trends and clinical characteristics of measles in Iraq (2023-2024): a retrospective cross-sectional study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Laboratory Parameters and Clinical Presentation of Children with Measles on Hospital Admission: Single-center Study from Sarajevo, Bosnia and Herzegovina.Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMeasles remains a major public health challenge globally, particularly in regions with low vaccination coverage. Iraq has experienced recurrent outbreaks in recent years, primarily due to inconsistent vaccination rates and a weakened healthcare system. This study aims to analyze the epidemiological patterns and clinical features of measles in Iraq to develop effective public health interventions.
methodsThis retrospective cross-sectional study examined measles cases reported from January 2023 to August 2024, utilizing data from the national surveillance system. The analysis emphasized demographic and clinical information, specifically vaccination status, and clinical symptoms. Statistical analyses were performed using SPSS version 25, incorporating descriptive statistics, logistic regression, and Chi-square tests.
resultsThe measles incidence in Iraq increased significantly from 22.1 to 69.3 cases per 100,000 population. Notable rises in cases were observed among infants under 9 months (12% to 16.7%) and individuals over 15 years (6.4% to 12.1%). The percentage of cases with unknown vaccination status rose from 42.5% to 50.2%. Symptoms such as fever and rash were prevalent, exhibiting significant variations by age and vaccination status.
conclusionThe resurgence of measles in Iraq from January 2023 to August 2024 highlights significant public health challenges driven by socio-economic instability. The increase in cases, particularly among under-immunized populations and infants, necessitates urgent action. Strengthening vaccination programs, enhancing public awareness, and improving healthcare access are essential. Additionally, better surveillance and record-keeping are crucial for effective outbreak management. Tailored public health strategies are needed to address geographic disparities in incidence, and further research on vaccine hesitancy is critical for developing robust catch-up vaccination campaigns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.